Last week, stock markets were rocked by a wave of sell recommendations. Many experts recommended selling stocks and investing in safer investments.
– On our own behalf –
Tip: Trade your stocks now for €0.00 at finanzen.net zero! Find out here
14th place: The ranking
Investors who want to buy or sell stocks often consult analyst opinions. In the last trading week, numerous experts again advised getting out of stocks. These shares were recommended for sale by the analysts.
Source: finanzen.net, Image: Lightspring / Shutterstock.com
13th place: Kering
The private bank Berenberg has left the rating for Kering at “Sell” with a price target of 190 euros. For analysis
Source: finanzen.net, Image: Piotr Swat / Shutterstock.com
12th place: Carl Zeiss Meditec
The US bank JPMorgan has left the rating for Carl Zeiss Meditec at “Underweight” with a price target of 35.10 euros. For analysis
Source: finanzen.net, image: Carl Zeiss Meditec
11th place: Gerresheimer
The US analysis firm Bernstein Research has raised the price target for Gerresheimer from 25.60 to 25.68 euros and left the rating at “Underperform”. For analysis
Source: finanzen.net, Image: Daniel Gebauer / Gerresheimer AG
10th place: Ahold Delhaize
The US bank JPMorgan has left the rating for Ahold Delhaize at “Underweight”. For analysis
Source: finanzen.net, Image: Casimiro PT / Shutterstock.com
9th place: L’Oréal
Deutsche Bank Research has left the rating for L’Oréal at “Sell” with a price target of 340 euros. For analysis
Source: finanzen.net, Image: Arseniy Krasnevsky / Shutterstock.com
8th place: K+S
The major Swiss bank UBS has lowered the price target for K+S from 11.50 to 10.50 euros and left the rating at “Sell”. For analysis
Source: finanzen.net, image: K+S
7th place: WACKER CHEMIE
Deutsche Bank Research has lowered the price target for WACKER CHEMIE from 60 to 59 euros and left the rating at “Sell”. For analysis
Source: finanzen.net, image: WACKER Chemie
6th place: LANXESS
The major Swiss bank UBS has lowered the price target for LANXESS from 23 to 14 euros and downgraded the shares from “Neutral” to “Sell”. For analysis
Source: finanzen.net, image: LANXESS
5th place: AstraZeneca
Deutsche Bank Research has left AstraZeneca at “Sell” with a price target of 10,500 pence. For analysis
Source: finanzen.net, Image: Oli Scarff/Getty Images
4th place: Zurich
The major Swiss bank UBS has left the rating for Zurich at “Sell” with a price target of 520 francs. For analysis
Source: finanzen.net, image: www.zurich.de
3rd place: DocMorris
The major Swiss bank UBS has left the rating for DocMorris at “Sell” with a price target of 5.50 francs. For analysis
Source: finanzen.net, Image: Ralf Liebhold / Shutterstock.com
2nd place: Beiersdorf
The major Swiss bank UBS has left the rating for Beiersdorf at “Sell” with a price target of 92 euros. For analysis
Source: finanzen.net, image: Beiersdorf
1st place: Hapag-Lloyd
The British investment bank Barclays has raised the price target for Hapag-Lloyd from 92 to 94 euros, but left the rating at “Underweight”. For analysis
Source: finanzen.net, image: Hapag-Lloyd